While in the case of survivin at least partial assembly was achieved, it is conceivable that each tumor-associated antigen will affect assembly in its own way, i.e. there will be many tumor-specific antigens that will exclude themselves from this strategy of antigen presentation and delivery simply because assembly will be hampered. Here, BIRC5 is linked to neoplasm.